
ALT ⚠️ **Popular weight-loss drugs now carry a warning about possible permanent vision loss.** The U.S. FDA has ordered new safety warnings for Ozempic, Wegovy, Mounjaro and other GLP-1 medications. The concern is a rare eye condition called NAION, which occurs when blood flow to the optic nerve is reduced. It can cause sudden, painless vision loss in one eye, and the damage can be permanent. The FDA reviewed 126 clinical trials involving more than 134,000 people. Researchers found approximately 6.4 cases per 100,000 person-years among GLP-1 users, compared with 3.8 among comparison groups. Although the risk appears very small, the potential consequences are serious. Anyone taking these medications who experiences sudden vision changes should seek immediate medical attention. **A medicine designed to improve health must also be carefully monitored for unexpected risks.**


















